Study for the Treatment of Chronic Idiopathic Urticaria With High Doses of AERIUS (Desloratadine) (Study P04849)
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
This study will investigate the effectiveness of desloratadine at doses higher (10 mg and 20
mg) than currently approved (5 mg) for the treatment of chronic idiopathic urticaria.
Subjects with chronic urticaria who are currently taking a second generation antihistamine
will be treated with desloratadine (5, 10, or 20 mg) for 28 days.